Enobia Pharma

Enobia Pharma

Verified
Alexion Pharmaceuticals, Inc (NASDAQ: ALXN) | World Leader in Treatments for Patients with Devastating and Rare Diseases

Launch date
Employees
Market cap
-
Net debt
-
Firm valuation
$160—240m (Dealroom.co estimates Aug 2011.)
Canada (HQ)
  • Edit

Recent News about Enobia Pharma

Edit

Tech stack

Group
Tech stackLearn more about the technologies and tools that this company uses.